Protect Pharmaceutical (Protect Pharmaceutical) EBIT

: $-0.00 Mil (TTM As of Jun. 2018)

View and export this data going back to 2006. Start your Free Trial

Protect Pharmaceutical's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2018 was $-0.00 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2018 was $-0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Protect Pharmaceutical's annualized ROC % for the quarter that ended in Jun. 2018 was %. Protect Pharmaceutical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2018 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Protect Pharmaceutical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2018 was -0.03%.

Protect Pharmaceutical EBIT Historical Data

The historical data trend for Protect Pharmaceutical's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Protect Pharmaceutical Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

EBIT

-0.02

-0.03

-0.04

-0.12

Protect Pharmaceutical Quarterly Data
	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18
EBIT																-0.10	-	-	-	-

Competitive Comparison

For the Conglomerates subindustry, Protect Pharmaceutical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Protect Pharmaceutical EV-to-EBIT Distribution

For the Conglomerates industry and Industrials sector, Protect Pharmaceutical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Protect Pharmaceutical's EV-to-EBIT falls into.

Protect Pharmaceutical EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

Protect Pharmaceutical (OTCPK:PRTT) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Protect Pharmaceutical's annualized ROC % for the quarter that ended in Jun. 2018 is calculated as:

	ROC % (Q: Jun. 2018 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2018 )	+	Invested Capital (Q: Jun. 2018 ))	/ count )
=	-0.004 * ( 1 - 0% )	/	( (0	+	0)	/ 1 )
=	-0.004	/	0
=	%

where

	Invested Capital		(Q: Mar. 2018 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0	-	0.046	-	( 0	-	max(0, 0.046	-	0	+	0	))
=	0

	Invested Capital		(Q: Jun. 2018 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.02	-	0.051	-	( 0.02	-	max(0, 0.051	-	0.02	+	0.02	))
=	0

Note: The Operating Income data used here is four times the quarterly (Jun. 2018) data.

2. Joel Greenblatt's definition of Return on Capital:

Protect Pharmaceutical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2018 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2018 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2018		Q: Jun. 2018
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-0.004	/	( ( (0 + max(-0.046, 0))	+	(0 + max(-0.051, 0)) )	/	1 )
=	-0.004	/	( ( 0	+	0 )	/	1 )
=	-0.004	/	0
=	%

where Working Capital is:

	Working Capital		(Q: Mar. 2018 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0.046	+	0	+	0)
=	-0.046

	Working Capital		(Q: Jun. 2018 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0.051	+	0	+	0)
=	-0.051

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2018) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Protect Pharmaceutical's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2018 )
	=	-0.001	/	3.229
	=	-0.03 %

Protect Pharmaceutical EBIT Related Terms

Thank you for viewing the detailed overview of Protect Pharmaceutical's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Protect Pharmaceutical (Protect Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Protect Pharmaceutical Corp (OTCPK:PRTT) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

12465 South Street, Suite 240, Draper, UT, USA, 84020

Website

https://www.inaiapp.com

Protect Pharmaceutical Corp has an organic solution to soil and crop protection, annual growth, and natural restoration upon the completion of crop cycles. The company uses its products to revitalize farming soil, produce organic, toxin-free crops, and meet the increasing global demand for agricultural sustainability initiatives.